Previous Close | 126.65 |
Open | 127.22 |
Bid | 128.26 x 400 |
Ask | 128.49 x 400 |
Day's Range | 126.91 - 129.22 |
52 Week Range | 74.75 - 142.00 |
Volume | |
Avg. Volume | 3,214,982 |
Market Cap | 51.051B |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | 83.36 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Dexcom stock shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.